ArticleJournal of medicinal chemistry2022

Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction.

John M Ketcham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.